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CD8+ T cells play an important role in host resistance to many viral infections, but the 
underlying transcriptional mechanisms governing their differentiation and functionality 
remain poorly defined. By using a highly virulent systemic and respiratory poxvirus infec-
tion in mice, we show that the transcription factor Bcl11b provides a dual trigger that 
sustains the clonal expansion of virus-specific effector CD8+ T cells, while simultaneously 
suppressing the expression of surface markers associated with short-lived effector cell 
(SLEC) differentiation. Additionally, we demonstrate that Bcl11b supports the acquisition 
of memory precursor effector cell (MPEC) phenotype and, thus, its absence causes near 
complete loss of lymphoid and lung-resident memory cells. Interestingly, despite having 
normal levels of T-bet and Eomesodermin, Bcl11b-deficient CD8+ T cells failed to exe-
cute effector differentiation needed for anti-viral cytokine production and degranulation, 
suggesting a non-redundant role of Bcl11b in regulation of this program. Thus, Bcl11b 
is a critical player in fate decision of SLECs and MPECs, as well as effector function and 
memory formation.
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inTrODUcTiOn
The murine model of vaccinia virus (VacV) infection has proven to be a powerful system for investi-
gating immune responses to highly virulent viruses. Vaccinia is a large DNA virus that replicates in 
the cytoplasm of infected cells. Systemic (i.p., or i.v.) or respiratory inoculation of immunocompetent 
mice with the mouse adapted Western Reserve strain (VacV-WR) results in an acute infection during 
which the virus replicates very rapidly to high titers, causes strong and sustained inflammation, 
and disseminates to multiple lymphoid and non-lymphoid tissues within the host (1–4). Activated 
macrophages (5), natural killer (NK) cells (6, 7), and γδ T cells (8) play an important role in the initial 
control of VacV (9). Adaptive immune responses mediated by CD4+, CD8+, and B-lymphocytes take 
Abbreviations: Ag, antigen; Cko, conditional knockout; Eomes, eomesodermin; LCMV, lymphocytic choriomeningitis virus; 
MPECs, memory precursor effector cells; SLECs, short-lived effector cells; VacV, vaccinia virus; WR, western reserve; WT, 
wild type.
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several days to develop and are necessary for complete clearance 
of virus from infected tissues (2, 10, 11). Upon reinfection, virus-
specific memory CD8+ T cells traffic to the lung parenchyma and 
airway lumen, mediating rapid clearance and providing protec-
tive immunity against otherwise lethal challenges (1, 12, 13).
In recent years, we have defined some of the key co-stimulatory 
pathways required to program naïve VacV-specific CD8+ T cells 
with different antigen specificities to expand, differentiate, and 
survive to become memory cells (14, 15). Surprisingly, however, 
little is known about the underlying transcriptional mechanisms 
that govern the development of functional virus-specific effector 
and memory CD8+ T cells after VacV infection.
During lymphocytic choriomeningitis virus (LCMV) infec-
tion, two members of the T-box transcription factor family, T-bet 
and eomesodermin (Eomes), cooperate to induce expression of 
IFN-γ, perforin, and granzyme B by early effector CD8+ T cells 
(16). Interestingly, they also seem to have discrete functions (16). 
For example, high levels of T-bet have been associated with differ-
entiation of short-lived effector cells (SLECs), which are defined 
by the upregulation of KLRG1 and the loss of IL-7Rα (CD127). 
Conversely, early expression of Eomes has been shown to favor 
the formation of memory precursor effector cells (MPECs) that 
express low levels of KLRG1 and increased levels of CD127 and 
IL-2 (17). Induction of T-bet in Ag-specific CD8+ T cells is medi-
ated initially by TCR signaling and amplified by IL-12 (18, 19). 
The expression of Eomes appears to be induced subsequently to 
that of T-bet and can be amplified by IL-2, but suppressed by IL-12 
(18, 20). Accordingly, IL-12 has been proposed to be a molecular 
switch between SLEC and MPEC cell fate decision by promoting 
high levels of T-bet expression while suppressing Eomes. Further 
studies have implicated numerous other transcription factors in 
SLEC vs. MPEC cell fate decision with Blimp-1, and Id2 favoring 
SLEC formation and Bcl-6, Tcf1, FOXO1, STAT3, and Id3 expres-
sion supporting the formation of MPECs (16). Thus, coordinated 
and dynamic expression of multiple transcription factors ensures 
formation of distinct effector and memory populations under 
various physiological conditions. Whether other transcription 
factors participate in overlapping or complimentary pathways in 
the differentiation of effector and memory CD8 T cell responses 
to viral pathogens in vivo is not well defined.
Bcl11b is a C2H2 zinc finger transcription factor known to 
function as both a transcriptional activator and repressor depend-
ing on its interacting partners (21). In T cells, Bcl11b expression 
begins in the DN2 state of thymocyte development and continues 
as thymocytes mature (22). Bcl11b is also expressed in mature 
CD4+ and CD8+ T cells (23–25) and innate lymphoid cells (26) 
as well as in regulatory T (Treg) cells (27) and invariant Natural 
Killer T (iNKT) cells in the thymus and periphery (28,  29). 
Our recent report suggested that priming of CD8+ T cells in 
lymphoid tissues is compromised in the absence of Bcl11b (24). 
After systemic infection with Listeria monocytogenes, Bcl11b 
was shown to be required for antigen (Ag)-dependent clonal 
expansion in the spleen (24). Furthermore, after respiratory 
influenza virus infection, the frequency of nucleoprotein (NP)- 
and polymerase complex PA subunit (PA)-specific effector 
Bcl11b-deficient CD8+ T cells in the mediastinal lymph nodes 
was significantly reduced (24). While these studies demonstrated 
that Bcl11b drives CD8+ T cell proliferation and effector function 
in the lymphoid compartment, little is known regarding the role 
of Bcl11b as potentially driving effector and/or memory CD8+ 
T cell differentiation in mucosal tissues. In the present study, we 
used a conditional knock out (Cko) mouse model to compare 
the requirement for Bcl11b in CD8+ T cell responses induced 
in the spleen and lung microenvironments after systemic and 
respiratory VacV infection. We report that the absence of Bcl11b 
during priming of CD8+ T cells has major phenotypic, cell fate, 
and functional consequence on the effector and memory cells 
generated during an immune response to VacV infection.
MaTerials anD MeThODs
Mice
Eight- to 12-week-old female Bcl11bflox/flox/dLck-iCre+ mice on 
C57BL/6 background and wild-type littermate mice were bred 
and maintained at the University of Florida animal facility. 
Bcl11bflox/flox/dLck-iCre+ mice were previously described (23–25). 
This study was carried out in strict accordance with the recom-
mendations in the Guide for the Care and Use of Laboratory 
Animals of the animal Welfare Act and the National Institutes of 
Health guidelines for the care and use of animals in the biomedical 
research. All animal protocols were approved by the Institutional 
Animal Care and Use Committee (IACUC) of the University of 
Florida, Gainesville (OLAW Assurance # A3377-01).
Peptides and Tetramers
Vaccinia virus peptide epitopes used in this study were predicted 
and synthesized as described previously (30, 31). The VacV-WR 
peptide B8R20–27 (TSYKFESV) and A8R189–196 (ITYRFYLI) (30, 
31) were purchased From A & A Labs (San Diego). MHC/peptide 
tetramers for the VacV Western Reserve (WR) epitope B8R (20-27; 
TSYKFESV)/H-2Kb, which were conjugated to allophycocyanin, 
were obtained from the National Institutes of Health Tetramer 
Core facility (Emory University, Atlanta, GA, USA).
Virus and Peptides
Vaccinia virus Western Reserve (VacV-WR) was purchased from 
the American Type Culture Collection (ATCC), grown in HeLa 
cells, and subsequently titered on VeroE6 cells as previously 
described (12).
Virus infections
Naïve mice were infected with 2.0 × 105 plaque forming unit (PFU) 
VacV-WR by bilateral i.p. injections. For respiratory VacV-WR 
infection model, naïve mice were anesthetized by isoflurane 
inhalation and infected intranasally (i.n.) with 1.25 × 104 PFU of 
VacV-WR, with daily measurements of body weight [as described 
before (1, 2)]. Body weight was calculated as percentage of the mean 
weight for each mouse on the day of challenge. Effector responses 
were analyzed between days 8 and 15 postinfection, while memory 
responses were analyzed 40 or more days after infection.
VacV-Titer assay
Tissues from individual mice were homogenized, and sonicated 
for 0.5 min with a pause every 10 s using an ultrasonic cleaner 
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1210 Branson (Danbury, CT, USA). Serial dilutions were made 
and the virus titers were then determined by plaque assay on 
confluent VeroE6 cells.
Flow cytometric and Facs analysis
Preparation of cells, extracellular and intracellular staining, FACS 
data acquisition, and analysis were performed as described previ-
ously (1, 11, 32). Briefly, all tissues were aseptically removed from 
euthanized mice, and single-cell suspensions were prepared by 
mechanically dispersing the tissues through 70-μm cell strainers 
(Falcon BD Labware) into HBSS. Lung tissue was treated for 1 h 
at 37°C with 25°μg Librase TL (Roche) followed by treatment 
for 10  min at 4oC with 100°μM EDTA supplemented media. 
Following lysing RBC, splenocytes from infected mice were 
resuspended in RPMI 1640 medium (Life Technologies) sup-
plemented with 10% FCS (Omega Scientific), 1% l-glutamine 
(Invitrogen), 100 mg/ml streptomycin, 100 U/ml penicillin, and 
50 mM 2-ME (Sigma-Aldrich).
T Cell Subsets
Cells were washed with FACS buffer [phosphate buffered saline 
(PBS) and 2% FCS] and stained with anti-Fc II/III receptor 
monoclonal antibody 2.4G2 for 15 min at 4°C. After an additional 
FACS buffer wash, the following antibodies were incubated with 
the cells for 30  min at 4°C: CD4 (RM4-5, eBioscience), CD8α 
(53-6.7, eBioscience), CD3 (145-2C11, eBioscience), CD44 
(IM7, eBiosience), and B8R tetramer (NIH tetramer facility) 
were used to determine total T cell and VacV-specific CD8 T cell 
subsets. Isolated spleen and lung B8R+ CD8 T cells from WT and 
Bcl11b−/− mice were also stained for their surface expression of 
KLRG-1 (eBioscience) and IL-7Ra (eBioscience). All samples 
were acquired on a FACS LSR II or Canto II (BD Bioscience) and 
analyzed using FlowJo (Tree Star).
VacV-Specific Cytokine Production
One to 2 × 106 cells were plated in round-bottom 96-well micro-
titer plates in 200 μl with medium or the indicated VacV peptides 
at 1  μg/ml for 1  h at 37°C. GolgiPlug (BD Biosciences) and 
anti-CD107α (1D4B, eBioscience) was then added to the cultures 
according to the manufacturer’s instructions and the incubation 
was continued for 8 h. Cells were stained with anti-CD8 (PerCP; 
53-6.7) and CD62L (PE; MEL-14), followed by fixation with 
Cytofix/Cytoperm (BD Biosciences) for 20 min at 4°C. Fixed cells 
were subjected to intracellular cytokine staining in BD Perm/Wash 
buffer for 30 min at 4°C. Anti-IFN-γ (allophycocyanin; XMG1.2), 
anti-TNF (MP6-XT22; PE Cy7), and anti-IL-2 (JES6-5H4) were 
obtained from eBiosience and used at a 1/150 dilution. Samples 
were analyzed for their proportion of cytoplasmic cytokines after 
gating on CD8+CD62Llow T cells by a FACSCalibur flow cytometer 
using CellQuest (BD Biosciences) and FlowJo software (Tree Star).
statistical analysis
Tests were performed using the Prism 5.0 software (GraphPad, 
San Diego, CA, USA). Statistics were done using two-tailed, 
unpaired Student’s t-test with 95% confidence intervals unless 
otherwise indicated. Unless otherwise indicated, data represent 
the mean ± SEM; p < 0.05 considered statistically significant.
resUlTs
requirement for Bcl11b in Primary VacV-
specific cD8+ T cell expansion in 
lymphoid vs. Mucosal compartment
Whether Bcl11b contributes to the development and maintenance 
of memory CD8+ T cells in lymphoid and mucosal tissues is not yet 
known; to address this, we first asked whether Bcl11b contributes 
to the clonal expansion of VacV-specific effector CD8+ T cells. 
Because Bcl11b is expressed by multiple cell types, we generated 
Cko mice by crossing mice expressing the codon-improved Cre 
recombinase (iCre) under the control of the Lck distal promoter 
(dLck-iCre) with mice homozygous for loxP-flanked allele of 
Bcl11b (Bcl11bflox/flox) (24, 25). In the resultant Bcl11bflox/flox/dLck-
iCre+ mice, Bcl11b is expressed normally in CD4+CD8+ double-
positive thymocytes as well as in CD4+ and CD8+ single-positive 
thymocytes; therefore, thymic T cell development is not affected 
in this system (24). However, the floxed Bcl11b allele is removed 
in ~85–90% of peripheral CD8+ T cells (24). For simplicity, the 
Bcl11bflox/flox/dLck-iCre+ mice will be referred to as Bcl11b−/− Cko 
mice and Bcl11bflox/flox/dLck-iCre− littermate controls will be 
referred to as WT mice.
In initial experiments, we focused on systemic priming so it 
would not provide a bias to generating mucosa-associated CD8+ 
T cells. Cohorts of naïve, Bcl11b−/− Cko, and WT littermate con-
trol mice were infected intraperitoneally (i.p.) with a sub-lethal 
inoculum of VacV-WR. On day 8, the reported peak of the primary 
effector response (1, 12), we tracked VacV-specific CD8+ T cells 
in the spleen and lung through the use of H-2Kb tetramers loaded 
with the immunodominant peptide epitope of VacV B8R protein 
(B8R20–27/kb) (30). In WT control mice, VacV infection induced a 
vigorous expansion of CD8+ T cells (Figures 1A,B). Notably, both 
the percentages and absolute numbers of B8R20–27/kb-reactive 
effector population in the spleen and lung corresponded closely 
to those obtained in non-transgenic WT C57BL/6 mice (1, 12). In 
stark contrast, total numbers of activated (CD44hi) and B8R20–27/
kb-reactive CD8+ T cells were significantly reduced in both 
tissues sampled from Bcl11b−/− Cko mice (Figures 1A,B). This 
was not due to impaired activation of CD8+ T cells in that CD44 
(Figures 1A,B) and CXCR3 (Figure S1 in Supplementary Material) 
were similarly elevated in Bcl11b−/− Cko mice. Downregulation of 
CD62L was also not different between Bcl11b−/− Cko and WT 
cells (not shown). Impaired accumulation of VacV-specific CD8 
T cells in the absence of Bcl11b was also observed on day 14, 
indicating that the defect cannot be explained by delayed kinetics 
of expansion (Figures 1C,D).
In the spleen of infected Bcl11b−/− Cko mice, activated CD8+ 
T cells that stained positive for the proliferation marker Ki67 were 
reduced by 70–95% (Figures 2A,B), supporting our prior data 
that Bcl11b regulates proliferation of T cells responding to Listeria 
monocytogenes and influenza PR8 strain (24). Interestingly, per-
centages of CD8+CD44hi T cells capable of proliferating (Ki67+) 
in response to VacV were not reduced in the lungs of Bcl11b−/− 
Cko mice (Figures 2A,B; Bottom Panels). However, the reduced 
numbers of virus-specific CD8+ T cells generated translated into 
significant deficiencies in the accumulation of Ki67+ effector 
FigUre 2 | Bcl11b controls the magnitude of expansion of virus-specific cD8 T cells in response to VacV-Wr infection. WT (Bcl11bflox/flox/dLck-iCre−; 
n = 8) or Bcl11b-conditional knockout (Bcl11bflox/flox/dLck-iCre+; n = 7) mice were infected i.p with VacV-WR (2 × 105 PFU/mouse). Eight (a) and 14 (B) days 
postinfection, splenocytes and lung cells were harvested and stained for CD8, CD44, and Ki67. (a,B) Left, Representative plots showing the percentage of CD8 T 
cell proliferation by Ki67 staining among CD44hi cells in VacV-infected mice. Right, total numbers and percentages of CD8+CD44hiKi67+ cells per spleen and lung. 
Quadrant settings were based on controls, after gating on naïve CD44lo cells in the same host. Percentages that stained positive for each marker are indicated. The 
results shown are representative of two separate experiments each with three to four mice per group. Asterisks indicate statistical significance. The p-values are 
<0.05 by two-tailed Student t-test (WT vs. Cko).
FigUre 1 | Bcl11b is required for optimal accumulation of VacV-specific effector cD8 T cells. WT (Bcl11bflox/flox/dLck-iCre−; n = 8) or Bcl11b-conditional 
knockout (Bcl11bflox/flox/dLck-iCre+; n = 7) mice were infected i.p with VacV-WR (2 × 105 PFU/mouse). Eight (a,B) and fourteen (c,D) days postinfection, splenocytes 
and lung cells were harvested and stained for CD8, CD44, and B8R20–27/kb tetramer. (a–D) Left, representative plots of CD8/CD44 (Top Panels) and CD8+CD44hi 
B8R20–27/kb-tetramer staining (Bottom Panels), gating on live cells, are shown. Percentages of activated (CD44hi) and B8R20–27/kb tetramer + CD8 T cells within each 
gate are indicated. Right, percentages and total numbers of CD8+CD44hi and B8R20–27/kb tetramer + cells per spleen (a,c) and lung (B,D). Quadrant settings were 
based on controls, after gating on naïve CD44lo cells in the same host. The results shown are representative of two separate experiments each with three to four 
mice per group. Asterisks indicate statistical significance. The p-values are <0.05 by two-tailed Student t-test (WT vs. Cko).
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FigUre 3 | enhanced effector phenotype and loss of memory precursor effector cD8 T cells in the absence of Bcl11b. WT (Bcl11bflox/flox/dLck-iCre−; 
n = 8) or Bcl11b-conditional knockout (Bcl11bflox/flox/dLck-iCre+; n = 7) mice were infected i.p with VacV-WR (2 × 105 PFU/mouse). Eight (a) and 14 (B) days 
postinfection, splenocytes and lung cells were harvested and stained for CD8, CD44, IL-7Rα, KLRG1, and B8R20–27/kb tetramer. (a,B) CD8 T cell differentiation was 
assessed with upregulation of KLRG1 and downregulation of IL-7Rα (CD127) on B8R20–27/kb tetramer+ cells. Quadrant settings were based on controls, after gating 
on naïve CD44lo cells in the same host. Percentages that stained positive for each marker are indicated. The results shown are representative of two separate 
experiments each with three to four mice per group. Asterisks indicate statistical significance. The p-values are <0.05 by two-tailed Student t-test (WT vs. Cko).
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T cells (Figures 2A,B), indicating that Bcl11b might additionally 
influence the survival of cells that are destined to accumulate in 
the lungs.
Bcl11b-Deficient cD8+ T cells adopt a 
Terminally Differentiated effector 
Phenotype
Next, we assessed whether the defective accumulation of virus-
specific CD8+ T cells in infected tissues reflected a reduction 
in total effector cell numbers or a decrease in a specific stage of 
differentiation in response to VacV infection. To determine this, 
B8R20–27/kb-reactive cells were examined for expression of the co-
inhibitory receptor killer-cell lectin-like receptor G1 (KLRG1) 
and IL-7 receptor alpha-chain (IL-7R) (19). Four major matura-
tion and functional effector cell subsets were identified: a MPEC 
population characterized as KLRG1loIL-7Rhi (Figures  3A,B, 
lower right quadrants); an early effector cell (EEC) population 
defined as KLRG1loIL-7Rlo (Figures 3A,B, lower left quadrants); 
a terminally differentiated KLRG1hiIL-7Rlo SLEC population 
(Figures 3A,B, upper left quadrants); and a terminally differenti-
ated KLRG1hiIL-7Rhi double-positive cell (DPC) (Figures 3A,B, 
upper right quadrants). During the expansion (day 8; Figure 3A) 
and contraction (day 14; Figure 3B) phases of the response, in 
Bcl11b−/− Cko mice, the response to VacV was dominated by SLEC 
generation with relatively few MPECs and EECs present within 
the effector pool. Thus, during the priming phase of naïve CD8+ 
T cells, Bcl11b assimilates TCR and proinflammatory signals, 
ensuring proper expansion of effector T cells while restraining 
their commitment toward the SLEC lineage.
Bcl11b is necessary for acquisition of 
Optimal effector Function by cD8+ T cells
High KLRG1 expression is a useful marker of multifunctional 
CD8+ T cells with potent cytolytic activity and the capacity to 
produce large quantities of anti-viral cytokines. Because Bcl11b 
deficiency was associated with acquisition of SLEC (KLRG1hi) 
phenotype, we hypothesized it might also be associated with 
enhanced expression of cytolytic effector molecules by virus-
specific effector CD8+ T cells. First, we examined the expression 
of the lysosomal-associated membrane protein-1 (LAMP-1 or 
CD107a), which appears on the surface of CD8+ T cells when 
they release their pre-formed cytolytic granules (containing 
FigUre 4 | cD8 T cells lacking Bcl11b are defective in lytic activity and anti-viral cytokine production after systemic infection with VacV. WT 
(Bcl11bflox/flox/dLck-iCre−; n = 8) or Bcl11b-conditional knockout (Bcl11bflox/flox/dLck-iCre+; n = 7) mice were infected i.p with VacV-WR (2 × 105 PFU/mouse). Eight 
days postinfection, splenocytes and lung cells were harvested and stimulated with B8R peptide for 8 h and subsequently stained for CD8α, CD107a, and 
intracellular IFN-γ and TNF. Representative plots for CD107a (a), IFN-γ (B), TNF (c), CD107a/IFN-γ (D), CD107a/TNF (e), and IFN-γ/TNF (F) staining in gated 
CD8+CD44+ T cells. Numbers indicate percentages of positive cells or mean fluorescence intensity (MFI in red) within the gated population. Gates were based on 
controls, after gating on CD44lo cells in the same host as well as using infected cells that were not stimulated with peptide and uninfected cells stimulated with B8R 
peptide for cytokine analysis (data not shown). The results shown are representative of two separate experiments each with three to four mice per group. The 
p-values are <0.05 by two-tailed Student t-test (WT vs. Cko).
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granzyme and perforin) in response to recognition of virus-
infected cells and, therefore, is widely used as a marker of 
degranulation and cytolytic activity (33). On day 8 of infection, 
total spleen and lung cells were stimulated directly ex vivo for 
8 h with the immunodominant VacV-derived peptide epitope, 
B8R (Figure 4A), or subdominant A8R peptide epitope (Figure 
S2 in Supplementary Material). As expected in WT mice, a large 
fraction of spleen (35–40%) and lung (50–60%) VacV-reactive 
FigUre 5 | Bcl11b deficiency does not affect T-bet and eomes 
expression levels in VacV-specific cD8 T cells. WT (Bcl11bflox/flox/
dLck-iCre−) or Bcl11b-conditional knockout (Bcl11bflox/flox/dLck-iCre+) mice 
were infected i.p with VacV-WR (2 × 105 PFU/mouse). Eight days 
postinfection, splenocytes and lung cells were harvested and subsequently 
stained for CD8α, CD44, T-bet, Eomes, and B8R20–27/kb tetramer. 
Representative plots for T-bet (a) and Eomesodermin (B) staining gated on 
CD8+CD44+ B8R20–27/Kb-tetramer+ cells recovered from the spleen and lung 
as indicated. Numbers indicate mean fluorescence intensity (MFI) within the 
gated population. Gates were based on controls, after gating on CD44lo 
cells (Gray shaded area) in the same host. The p-values are <0.05 by 
two-tailed Student t-test (WT vs. Cko).
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CD8+ T cells expressed surface CD107a after peptide stimula-
tion (Figure  4A and Figure S2 in Supplementary Material), 
indicating that extensive degranulation had occurred within 
the responding population. Remarkably, however, the majority 
of CD8+ T cells from Bcl11b−/− Cko mice failed to degranulate 
following ex vivo peptide stimulation (Figure 4A). This observa-
tion was reflected in both the percentages (Figure  4A) and 
absolute numbers (not shown) of CD107a-positive effector cells 
present in the lung and spleen of infected mice. Furthermore, 
using mean fluorescence intensity (MFI) analysis, we found 
reduced levels of surface CD107a on Bcl11b−/− Cko CD8+ T cells 
(Figure  4A), with an average MFI reduction between 40 and 
70%. These results demonstrate that Bcl11b−/− Cko effector 
CD8+ T cells produced fewer cytolytic effector molecules on 
a per-cell basis.
To further investigate the effects of Bcl11b expression, we ana-
lyzed CD8+ T cells for their capacity to produce IFN-γ and TNF 
following B8R (Figure 4B) or A8R (Figure S2 in Supplementary 
Material) peptide stimulation. Both peptides readily induced 
IFN-γ (Figure  4B and Figure S2 in Supplementary Material) 
and TNF (Figure 4C and Figure S2 in Supplementary Material) 
production in lung and splenic effector cells recovered from 
WT infected mice. However, relatively few IFN-γ- and TNF-
expressing CD8+ cells could be detected in Bcl11b−/− Cko mice 
(Figures 4B,C). In agreement with our CD107a data, the overall 
amount of IFN-γ and TNF produced on a per-cell basis (MFI) 
was lower in Bcl11b−/− cells than in their WT counterparts.
Next, costaining for CD107a and IFN-γ or TNF was performed 
on VacV-reactive effector CD8+ T cells to determine if Bcl11b 
differentially impacted subsets within the CD107a+ population. 
In the WT spleen, ~55% of CD107a+ cells expressed IFN-γ 
(Figure 4D) and 15% expressed TNF (Figure 4E), whereas in the 
lung, ~95% of CD107a+ cells expressed IFN-γ. Bcl11b deficiency 
reduced the frequency of CD8+ CD107a+ T cells that produced 
IFN-γ and to a lesser extent TNF (Figures  4D,E; upper right 
quadrants). Similar results were found for CD8+ CD107a+ T cells 
that produced both IFN-γ and TNF (Figure 4F). Overall, these 
data demonstrate that in VacV-specific effector CD8+ T cells, 
Bcl11b is part of a transcriptional program that represses the 
formation of SLECs and simultaneously enhances lytic activity 
as well as expression of two major proinflammatory anti-viral 
cytokines, IFN-γ and TNF.
Bcl11b controls cD8 T cell effector 
Function independently of T-Bet and 
eomes
To date, several transcription factors have been identified as 
being critical for effector vs. memory CD8+ T cell differentiation 
in both viral and intracellular bacteria models of infection. Of 
crucial importance for SLEC differentiation is T-bet (19, 34, 35). 
Conversely, T-bet’s homolog, Eomes controls IL-15-dependent 
memory CD8+ T cell formation through directly activating Il2rb 
transcription (17). In addition, Eomes and T-bet cooperate to 
induce expression of Ifng, GzmB, and perforin and, thus, CTL 
effector function (16). As Bcl11b influenced MPEC/SLEC fate 
decision and function during VacV infection, we speculated 
that it might play a role in the balance of T-bet and Eomes in 
effector CD8+ T cells. Analysis of B8R20–27/kb-tetramer+ cells in 
both the spleen and lung showed that nearly all WT effector 
CD8+ T cells had upregulated T-bet (Figure  5A) and Eomes 
(Figure 5B) at the peak of the VacV response. Most strikingly, 
FigUre 6 | Bcl11b is required for optimal generation of memory cD8 T cells after systemic infection with VacV. WT (Bcl11bflox/flox/dLck-iCre−) or 
Bcl11b-conditional knockout (Bcl11bflox/flox/dLck-iCre+) mice were infected i.p with VacV-WR (2 × 105 PFU/mouse). Sixty days postinfection, splenocytes and lung 
cells were harvested and stained for CD8, CD44, Ki67, and B8R20–27/kb tetramer. (a,B) Left, representative plots of CD8/CD44 (Top Panels) and CD8+CD44hi 
B8R20–27/kb-tetramer staining (Bottom Panels), gating on live cells, are shown. Percentages of activated (CD44hi) and B8R20–27/kb tetramer + CD8 T cells within each 
gate are indicated. Right, percentages and total numbers of CD8+CD44hi and B8R20–27/kb tetramer + cells per spleen (a) and lung (B). (c) Total numbers of B8R20–27/
kb tetramer + cells in spleen and lung at day 8 and 60 post infection. Numbers in red indicate the fold-decrease of response between days 8 vs. 60 within each 
group. (D) Left, representative plots showing the percentage of CD8 T cell proliferation by Ki67 staining among CD44hi cells in VacV-infected mice. Right, 
Percentages and total numbers of CD8+CD44hiKi67+ cells per spleen and lung. Quadrant settings were based on controls, after gating on naïve CD44lo cells in the 
same host. Percentages that stained positive for each marker are indicated. The results shown are representative of two separate experiments each with four mice 
per group. Asterisks indicate statistical significance. The p-values are <0.05 by two-tailed Student t-test (WT vs. Cko).
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Bcl11b deficiency did not cause a decrease in the frequencies of 
B8R20–27/kb-reactive, T-bet+ CD8+ T cells compared with WT cells 
recovered from the spleen. Of note, in the lung, T-bet MFI in 
Bcl11b−/− cells was slightly higher than WT cells, in line with their 
more pronounced terminally differentiated SLEC phenotype 
(Figure 5A). Similarly, we found that Bcl11b deficiency in CD8+ 
T cells resulted in a modest but reproducible increase in Eomes 
expression (Figure 5B). Together, these results provide evidence 
that the markedly impaired VacV-induced degranulation and 
anti-viral cytokines production by Bcl11b−/− CD8 T cells was not 
caused by inadequate induction or altered balance between T-bet 
and Eomes. This implies important non-redundant roles for 
Bcl11b in mediating cytolytic activity and production of IFN-γ 
and TNF by VacV-specific CD8+ T cells.
Next, we considered the possibility that difference in viral load 
between WT and Bcl11b−/− mice might have dramatic conse-
quence on the differentiation and function of VacV-specific CD8 
T cells, possibly leading to an exhausted phenotype. However, 
analysis of viral titers in the ovaries during both the acute (day 
8) and contraction (day 14) phases of the response did not 
reveal any significant differences in the kinetics of clearance in 
WT and Bcl11b−/− mice (Figure S3 in Supplementary Material). 
This is consistent with results in the i.p. infection model show-
ing that depletion of CD8 T cells has no major effect on initial 
VacV-WR titers (10).
impaired generation of Memory cD8+  
T cells in the absence of Bcl11b
Our data thus far demonstrated that lack of Bcl11b in virus-
specific CD8+ T cells results in an altered SLEC/MPEC ratio, with 
effector cells skewing more toward SLEC lineage. Therefore, our 
next set of experiments was designed to assess whether Bcl11b−/− 
effector CD8+ T cells would persist into the memory pool. Sixty 
days post infection, VacV-infected WT mice contained high 
frequencies of CD44hi memory CD8+ T cells specific for the 
B8R epitope, regardless of whether cells were recovered from 
the spleen (Figure  6A) or lungs (Figure  6B), although lungs 
contained higher percentage of B8R-reactive population. In 
Bcl11b−/− Cko mice compared with WT mice, we observed no 
significant differences in total CD8+ T cell numbers (not shown) 
FigUre 7 | lack of Bcl11b in cD8 T cells does not alter disease 
symptoms, weight loss recovery, or survival after respiratory 
VacV-Wr infection. WT (Bcl11bflox/flox/dLck-iCre−) or Bcl11b-conditional 
knockout (Bcl11bflox/flox/dLck-iCre+) mice were infected i.n. with VacV-WR 
(1.5 × 104 PFU/mouse). Animals were weighed daily and euthanized if weight 
loss was greater than 25% body weight. Mean% of initial body weight from 
indicated numbers of mice is shown.
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7–20), or survival profiles of VACV-infected mice. However, 
correlating with our data in the i.p. infection model, at the peak 
of the T cell response (day 8), we observed markedly reduced 
numbers of total activated (CD44hi) and B8R20–27/kb-reactive 
CD8+ T cells in the lung (Figure  8A) and spleen (Figure  8B) 
of Bcl11b−/− Cko mice compared with WT mice, and the IFN-γ 
response in both tissues was dramatically reduced (Figure 8C). 
As in the i.p. infection model, proliferation of CD8+ T cells 
in the spleen was reduced in the absence of Bcl11b, whereas 
proliferative responses of mucosal effector CD8+ T cells were 
largely unaffected (Figure  8D). Most significantly, however, 
15- to 20-fold fewer B8R20–27/kb-reactive memory CD8+ T cells 
were present in the spleen (Figure 9A) and lungs (Figure 9B) 
42  days after infection of Bcl11b−/− mice vs. WT mice. Thus, 
Bcl11b confers competitive fitness to memory cells located in 
the lung regardless of whether infection is via the peritoneal 
cavity or respiratory tract.
Again, both the percentages and MFI of IFN-γ- and TNF-
positive CD8 T cells present in the lung and spleen of VACV-
infected Bcl11b−/− mice were reduced compared with WT mice 
(Figures  9C,D,F,G). We previously found that Bcl11b directly 
regulates IL-2 in CD4+ T lymphocytes (36). Since IL-2 is important 
for formation of memory CD8 T cells, we examined intracellular 
IL-2 expression in the lung and spleen of WT and Bcl11b−/− mice. 
In contrast to expression of IFN-γ, we found that loss of Bcl11b 
had little or no effect on the ability of VacV-specific CD8 T cells to 
produce IL-2 in response to peptide stimulation (Figures 9E,H). 
Thus, Bcl11b may act to control the formation and/or survival of 
memory cells independently of IL-2.
DiscUssiOn
Here, we provide evidence that absence of Bcl11b during the 
immune response to VacV infection caused increased differentia-
tion of SLECs, while MPEC frequency was dramatically reduced. 
Interestingly, although the frequency of SLECs was increased in 
the absence of Bcl11b, these cells had reduced ability to produce 
IFN-γ and degranulate. Importantly, the few MPECs that formed 
in the absence of Bcl11b failed to accumulate over time and 
populate the memory pool in both lymphoid and mucosal tis-
sues. Thus, Bcl11b is an important regulator of MPEC vs. SLEC 
fate decision and, consequently, memory cell potential in virus-
specific CD8+ T cells.
An important observation in the current study is that 
Bcl11b−/− CD8+ T cells showed reduced capacity to produce 
IFN-γ and degranulate after peptide stimulation, even in the 
presence of normal levels of T-bet and Eomes. This was unex-
pected given that T-bet is essential for cytotoxic activity and 
optimal production of IFN-γ by VacV-specific CD8+ T cells (37). 
Currently, we do not know why T-bet and/or Eomes cannot 
function in the absence of Bcl11b but we are actively pursuing 
these lines of investigations. In this regard, we previously found 
that Bcl11b associates with genomic regions upstream of Gzmb 
and perforin transcriptional start site and enhanced the ability 
to trigger Ag-dependent killing by CD8+ T cells (24). Thus, the 
simplest explanation may be that T-bet requires Bcl11b to exert 
its full activity on the cytotoxic gene expression and effector 
and only a modest reduction in total CD44hi cell numbers. By 
contrast, very few B8R20–27/kb-reactive memory CD8+ T cells were 
formed in Bcl11b−/− Cko mice, irrespective of tissue sampled 
(Figures 6A,B). This may be, in large part, due to the reduced 
numbers of MPECs found in the absence of Bcl11b during the 
acute phase of the primary response to VacV, but might also 
reflect accelerated contraction and/or defective maintenance of 
Bcl11b−/− CD8+ T cells that follows after viral clearance. Indeed, 
the fold reduction in the number of B8R20–27/kb-reactive cells 
recovered from Bcl11b−/− mice vs. WT mice was substantially 
more between days 8 and 60 (spleen: ~25 vs. 18-fold; Lung: ~43 
vs. 9-fold) (Figure 6C), supporting the idea that Bcl11b might 
control survival of VacV-reactive MPECs beyond the phase 
of primary expansion. Interestingly, no significant difference 
between Bcl11b−/− Cko and WT mice was seen regarding the 
percentage of VacV-specific Ki67+ cells at day 60 postinfection 
(75–80%; Figure  6D), indicating that the progressive decline 
in the numbers of memory cells might be related to a survival 
disadvantage more than a defect in cytokine-driven homeostatic 
proliferation.
Bcl11b Drives effector and Memory cD8+ 
T cell responses Following respiratory 
VacV infection
It is noteworthy that we observed a strong reduction in virus-
specific effector and memory CD8+ T cells in the lungs, even 
though the animals were infected via i.p. injection. This raised 
the possibility that Bcl11b mediated signals might promote 
mucosal memory. To address this more directly, we infected 
WT and Bcl11b−/− Cko mice intranasally with a sub-lethal 
inoculum of VacV-WR and analyzed the effector and memory 
responses in these mice 8 and 42 days following infection. Bcl11b 
deficiency in CD8 T cells did not modify the kinetics of the 
initial weight loss (Figure 7; days 0–7), recovery (Figure 7; days 
FigUre 8 | Bcl11b expression is critical for the magnitude and functionality of primary effector cD8 T cells after respiratory infection with VacV. WT 
(Bcl11bflox/flox/dLck-iCre−; n = 8) or Bcl11b-conditional knockout (Bcl11bflox/flox/dLck-iCre+; n = 8) mice were infected i.n. with VacV-WR (1.5 × 104 PFU/mouse). Eight 
days postinfection, splenocytes and lung cells were harvested and stained for CD8, CD44, Ki67, and B8R20–27/kb tetramer. (a,B) Left, representative plots of CD8/
CD44 (Top Panels) and CD8+CD44hi B8R20–27/kb-tetramer staining (Bottom Panels), gating on live cells, are shown. Percentages of activated (CD44hi) and B8R20–27/kb 
tetramer + CD8 T cells within each gate are indicated. Right, percentages and total numbers of CD8+CD44hi and B8R20–27/kb tetramer + cells per spleen (a) and 
lung (B). (c) Representative plots for intracellular IFN-γ staining in gated CD8+CD44+ T cells. Settings were based on controls, after gating on naïve CD44lo cells in 
the same host. Percentages that stained positive for each marker are indicated. (D) Left, representative plots showing the percentage of CD8 T cell proliferation by 
Ki67 staining among CD44hi cells in VacV-infected mice. Right, percentages and total numbers of CD8+CD44hiKi67+ cells per spleen and lung. Settings were based 
on controls, after gating on naïve CD44lo cells in the same host. Percentages that stained positive for each marker are indicated. The results shown are 
representative of two separate experiments each with four mice per group. Asterisks indicate statistical significance. The p-values are <0.05 by two-tailed Student 
t-test (WT vs. Cko).
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function. Additionally, Bcl11b might be required to cooperate 
or regulate other transcription factors critical for CTL function, 
such as Blimp-1, recently found to be needed by T-bet for full 
CTL activity in the response to LCMV (38). T-bet and Blimp-1 
are both required for SLEC differentiation, in addition to CTL 
activity, however, Bcl11b negatively regulates this process, while 
sustaining the CTL activity, thus playing a unique role in CD8+ 
T  cells. How Bcl11b restricts SLEC differentiation but sustains 
CTL function remains to be established.
Most strikingly, absence of Bcl11b caused diminished forma-
tion of MPECs and ablated memory cell development in lung 
and lymphoid organs. Other transcription factors that control 
MPEC formation include Eomes, a T-box transcription factor 
highly homologous to T-bet and expressed in activated CD8+ 
T cells (17). Eomes controls IL-15-dependent memory CD8+ 
T cell formation through directly activating Il2rb transcription 
(17). Similar to T-bet, we found the protein levels of Eomes were 
not altered in VacV-specific Bcl11b−/− CD8+ T cells, suggesting 
that Bcl11b may act independently of Eomes in regulating the 
development of memory cells. Future studies should attempt 
to identify downstream targets of Bcl11b in CD8+ T cells and 
determine whether it can interact with or regulate other fate-
determining transcription factors.
Two other transcription factors, Id2 and Id3, known to 
negatively regulate the DNA-binding activity of E-proteins, 
were recently found to control the differentiation of SLECs and 
MPECs, respectively (39, 40). IL-2, IL-12, and IL-21 enhance 
Id2 expression in antigen-specific CD8+ T cells, while decreas-
ing Id3 expression (39). Id2 was found to control SLEC survival 
through Bim repression, and globally the transcriptional pro-
gram of SLECs, including cytokine expression (39, 40). Thus, it 
is possible that Bcl11b may work in concert with Id3 to generate 
MPECs and memory CD8+ T cells, while suppressing Id2 in 
restricting the SLEC program. FOXO1, a transcription factor 
inhibited by AKT signaling, plays a critical role in the formation 
of memory CD8+ T cells through the upregulation of memory 
signature transcription factors, such as Eomes, TCF7/TCF-1, 
and Id3, and the repression of terminal effector signature 
transcription factors, such as Blimp-1, T-bet, and Id2 (41). In 
this network of transcription factors, which regulate SLEC vs. 
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MPEC fate, we established so far that T-bet and Eomes are not 
downstream of Bcl11b, however it is of great interest to deter-
mine whether Bcl11b is regulated by T-bet and/or Eomes and/
or cooperates with them. Additionally, it would be important 
to further establish the position of Bcl11b in the network of 
transcription factors that regulate SLECs and MPECs and par-
ticularly the relationship with TCF7, Id2, Id3, Bcl-6, Blimp-1, 
and FOXO1.
FigUre 9 | Bcl11b expression is critical for the magnitude and functionality of memory cD8 T cells after respiratory infection with VacV. WT 
(Bcl11bflox/flox/dLck-iCre−; n = 9) or Bcl11b-conditional knockout (Bcl11bflox/flox/dLck-iCre+; n = 9) mice were infected i.n. with VacV-WR (1.5 × 104 PFU/mouse). 
Fourty-two days postinfection, splenocytes and lung cells were harvested and stained for CD8α, CD44, and B8R20–27/kb-tetramer (a,B) or stimulated with B8R 
peptide for 8 h and subsequently stained for CD8α, CD107a, and intracellular IFN-γ, TNF, and IL-2 (c–h). (a,B) Left, representative plots of CD8+CD44hi B8R20–27/
kb-tetramer staining after gating on live cells. Percentages of B8R20–27/kb tetramer + CD8 T cells within each gate are indicated. Right, Frequencies and total numbers 
(bar graphs) of B8R20–27/kb tetramer + cells per spleen (a) and lung (B). Representative dot plots (Top Panels) for CD107a/IFN-γ (c), CD107α/TNF (D), and CD107α/
IL-2 (e) staining in gated CD8+CD44+ T cells. Bar graphs of the percentages (Bottom Panels) of each cytokine within CD8+CD44+CD107a+ fraction are shown. 
Representative histogram plots (Top Panels) for IFN-γ (F), TNF (g), and IL-2 (h) gated on CD8+CD44+CD107a+ cells recovered from the spleen and lung as 
indicated. Numbers indicate percentages of positive cells or mean fluorescence intensity (MFI in red) within the gated population. Gates were based on controls 
(filled gray), after gating on CD44lo cells in the same host. Percentages that stained positive for each marker are indicated. Bar graphs of the MFI (Bottom Panels) of 
each cytokine within CD8+CD44+CD107a+ fraction are shown. The results shown are representative of two separate experiments each with three to four mice per 
group. Asterisks indicate statistical significance. The p-values are < 0.05 by two-tailed Student t-test (WT vs. knockout).
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responses of CD8+ T cells in lymphoid tissues may be a general 
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protective T cell memory against blood-borne and mucosal 
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